Factbox-Indian drugmakers with big US exposure as Trump plans pharmaceutical import tariffs
U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...
Indian drugmakers with big US exposure as Trump plans pharmaceutical import tariffs
U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...
January's $10 Billion M&A Deals And Bids Span Sectors
The January megadeals included transactions in the energy, financials, pharmaceuticals and materials sectors, signaling a ...
India Today on MSN6h
Dr Reddy's, Aurobindo Pharma: Why pharma stocks fell in early trade today?
The Nifty Pharma index dropped as much as 2% in early trade. Sun Pharma fell nearly 2%, Dr Reddy's dropped as much as 4%, and Aurobindo Pharma sank almost 6%. Cipla shares also fell.
Pharma Leaders to Meet Trump in Push to Tweak Drug Policies
The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...
Astrazeneca: ‘We’re too big to base our CEO’s pay on FTSE 100 peers’
Astrazeneca is too big and complex to base its CEO's pay on the rest of the FTSE index, according to the chair of its ...
2 ASX 200 pharmaceutical shares surging on big US news
The ASX 200 pharmaceutical share notes that US FDA Fast Track designation is designed to facilitate the development and ...
20 stocks of companies expected to put up numbers to back investors’ new ‘growth mindset’
The co-chief investment officers at Neuberger Berman see a new dynamic in the stock market as investors move on from ...
What J&J Is Trying to Achieve in Bankruptcy Court
Johnson & Johnson begins a two-week trial on Feb. 18 over its plan to end tens of thousands of lawsuits filed by women or ...
How Corporate America And Big Tech Are Forgetting About The Majority
All of this makes the head-spinning declarations of loyalty to the Trump Administration that many companies have shown in ...